Clarivate PLC (CLVT) company profile
Close on Nov 16, 2026Market cap $1.46BP/E –Yield –
About Clarivate
Services-Computer Processing & Data Preparation, SIC 7374
Clarivate Plc provides information, data, and analytics services across several primary segments, including Academia and Government, Intellectual Property, and Life Sciences and Healthcare. The company offers proprietary databases, scientific and academic content, intellectual property management tools, and specialized workflow technology designed to support research and development activities. Its offerings serve organizations and professionals navigating scientific exploration, academic publishing, patent administration, and clinical research.
The company maintains international operations spanning multiple regions, including North America, Europe, the Middle East, Africa, and the Asia-Pacific area. In addition to these broader territories, the text notes operations or business presences across individual jurisdictions such as the United States, the United Kingdom, India, and Israel. Clarivate is organized under the laws of Jersey, Channel Islands, and maintains its principal executive offices in London, United Kingdom.
Summary of the business section of Clarivate's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Clarivate PLC
- Headquarters
- St. Helier, Y9
- Address
- 4th Floor, St. Paul'S Gate, 22-24 New Street JE14TR
- Phone
- (207) 433-4000
- Website
- clarivate.com
- Employees
- 12,000, Dec 31, 2025
- Industry
- Services-Computer Processing & Data Preparation
- Incorporated in
- Y9
- Fiscal year ends
- December 31
- Auditor
- PricewaterhouseCoopers LLP, Philadelphia, Pennsylvania
Stock & identifiers
- Ticker
- CLVT
- Former tickers
- CCC until Feb 25, 2021
- Exchange
- NYSE
- IPO date
- Oct 29, 2018
- Shares outstanding
- 640M, Jun 30, 2026
- Public float
- $1.30B, Jun 30, 2025
- Filer category
- Large accelerated filer
- Stock splits
- 132-for-1, May 13, 2019
- SEC CIK
- 1764046
- CUSIP
- G21810109
- FIGI
- BBG00P1919G5
- Share class FIGI
- BBG00P1919H4
- EIN
- 00-0000000
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Tov Matitiahu S. Shem | Chief Executive Officer, Director | 2,611,385 |
| Henry Levy | President, LS&H | 719,797 |
| Michael M. Easton | Executive Vice President/CFO | 893,609 |
| Matthew J. Lisowski | Senior VP, CAO | 147,255 |
| Simon Webster | President, IP | 4,626,325 |
| Bar Veinstein | President, A&G | 1,263,016 |
| Jonathan Mark Collins | Executive Vice President/CFO | 1,145,554 |
| Maroun S. Mourad | President, IP | 1,021,926 |
| William E. Graff | EVP, Chief Information Officer | 857,962 |
| James Gordon Samson | President, IP | 1,248,522 |
| Andrew Miles Snyder | Director | 23,667,122 |
| Jane L. Okun Bomba | Director | 379,385 |
| Kenneth L. Cornick | Director | 2,126,457 |
| Wendell E. Pritchett | Director | 160,708 |
| Suzanne Heywood | Director | 93,979 |
| Saurabh Saha | Director | 170,601 |
| Michael J. Angelakis | Director | 15,775,995 |
| Valeria Alberola | Director | 91,158 |
| Richard Roedel | Director | 150,130 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 | $8.35M | $5.76M | $3.62M | $11 | $134 |
| FY2024 First PEO | $4.84M | $3.87M | $4.60M | $17 | $159 |
| FY2024 Second PEO | $21.87M | $1.62M | $4.60M | $17 | $159 |
| FY2023 First PEO | $12.48M | $10.58M | $5.68M | $31 | $145 |
| FY2023 Second PEO | $12.48M | $10.58M | $5.68M | $31 | $145 |
| FY2022 | $8.38M | $5.44M | $2.64M | $28 | $113 |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Executive compensation, fiscal 2025
Summary compensation table from the latest proxy statement
| Executive | Salary | Stock awards | Incentive pay | Other | Total | vs. prior year |
|---|---|---|---|---|---|---|
| Matti Shem Tov Chief Executive Officer | $900.00K | $6.40M | $918.00K | $133.47K | $8.35M | +72% |
| Jonathan Collins Executive Vice President, Chief Financial Officer | $750.00K | $2.67M | $765.00K | $14.26K | $4.20M | -29% |
| Bar Veinstein President, Academia & Government | $600.00K | $2.13M | $654.00K | $85.42K | $3.47M | -17% |
| Henry Levy President, Life Sciences & Healthcare | $600.00K | $2.13M | $648.00K | $14.26K | $3.40M | -18% |
| Maroun Mourad President, Intellectual Property | $189.04K | $2.25M | $160.69K | $6.55K | $2.61M | – |
| Gordon Samson Former President, Intellectual Property | $600.00K | $3.42M | – | $60.21K | $4.08M | -2% |
| Melanie Margolin Former Executive Vice President and Chief Administrative and Legal Officer | $136.99K | $1.76M | $136.99K | $1.94M | $3.97M | – |
Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.
Employees
Headcount reported in annual reports
“As of December 31, 2025 , we had more than 12,000 employees located in over 40 countries around the world.”
Corporate history
Events identified from SEC filings
See a number that looks wrong?